DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Identification and ultrasensitive quantification of H. pylori infections on gastric and stool human samples with a photonic label-free nanobiosensor
Helicobacter pylori is a widespread bacterium that infects the stomach, causing gastric disorders associated with high morbidity and mortality worldwide. Current methods for identifying and quantifying this pathogen rely on invasive and non-invasive tests. Although combining these methods allows accurate diagnosis, they have multiple drawbacks, and there is no single reliable gold standard test. New, more sensitive strategies involving molecular techniques, such as digital PCR, have been developed but require complex and expensive instruments. Herein, we implement and validat a nanophotonic bimodal waveguide (BiMW) biosensor for the sensitive and accurate detection of H. pylori in gastric biopsies and stool. This biosensor offers real-time, label-free detection, high sensitivity, and the capability to be integrated into compact devices. By employing monoclonal antibodies targeting specific membrane proteins found in H. pylori, the biosensor enables unique recognition of the bacterium, demonstrating its potential as an alternative diagnostic tool. The BiMW biosensor provides highly accurate H. pylori quantification in under 20 min, with limits of detection (LOD) of 89 ± 35 CFU/mL for antrum gastric biopsies and 82 ± 9 CFU/mL for stool samples. Clinical validation with 40 samples (20 gastric biopsies and 20 stool samples) showed sensitivity and specificity of 90 % for gastric biopsies and 95 % for stool samples, offering diagnostic reliability equivalent to semiquantitative ELISA tests and enabling more efficient and timely detection of H. pylori infections. This test can significantly improve the speed of diagnosis and contribute to the development of more effective strategies for H. pylori eradication., The ICN2 and the I3PT acknowledge the financial support received for the PyLOC project through the program ‘Seed Collaborative Projects CIBER-BBN-EHD’, funded by the Biomedical Research Networking Centre (CIBER). Alejandro Astúa acknowledges financial support from the European Union's Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie grant agreement No. 754397. The ICN2 is supported by the Severo Ochoa Centres of Excellence program, grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. The nanoB2A and the Grup de Recerca en Inflamació Gastrointestinal i Malalties Hepàtiques are consolidated research groups (‘Grup de Recerca’) of the Generalitat de Catalunya and are supported by the Departament de Recerca i Universitats de la Generalitat de Catalunya (No. 2021 SGR 00456 and 2021 SGR 01183). This work was also partially supported by the Instituto de Salud Carlos III, ISCIII-AES-FEDER (PI20/00817)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 CEX2021-001214-S
,
EC / H2020 754397
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20-00817
DOI: http://hdl.handle.net/10261/389314, https://api.elsevier.com/content/abstract/scopus_id/105002481886
HANDLE: http://hdl.handle.net/10261/389314, https://api.elsevier.com/content/abstract/scopus_id/105002481886